Cannabis executive salaries: who earned what in FY24 by Steve Jones October 16, 2024October 16, 2024 While the majority of Australia’s ASX-listed cannabis firms saw revenues climb in FY24, profitability often remained […]
Quarterly results: Elixinol; Emyria; Ecofibre; LGP; Bioxyne/BLS; Epsilon; Melodiol; MGC Pharma; AusCann; Neurotech; Wellnex Life; InhaleRx; Cannasouth by Steve Jones and Martin Lane November 1, 2023November 6, 2023
Financial results: Bioxyne/BLS; Emyria; Ecofibre; Zelira Therapeutics by Martin Lane October 3, 2023April 30, 2024
Second trial flagged by Ecofibre in bid to get S3 product over the line by Steve Jones February 1, 2023February 1, 2023
Company news: Emyria; Ecofibre; Avecho; Medlab; MGC Pharma; AusCann; Botanix; Incannex; GFI by Martin Lane and Steve Jones November 1, 2022April 29, 2024
Ecofibre launches low-cost CBD product and pins hope on OTC market to drive profitability by Steve Jones August 23, 2022April 29, 2024
Over-the-counter sales to create ‘most significant opportunity in years’ says Ecofibre boss by Steve Jones August 3, 2022April 29, 2024
Ecofibre; LGP; Creso Pharma; Rua Bioscience; The Pain Clinic; MGC Pharma by Martin Lane July 28, 2022April 29, 2024